Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors
- First Posted Date
- 2022-02-10
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- ES Therapeutics Australia Pty Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT05234762
- Locations
- 🇨🇦
Clinique Neuro-Levis, Levis, Quebec, Canada
ES-481 for Uncontrolled Glioma-Associated Epilepsy and Assessment for Potential Anti-Tumorigenic Effect in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Tumors
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- ES Therapeutics Australia Pty Ltd
- Registration Number
- NCT04737174
Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy
Phase 2
Recruiting
- Conditions
- Drug Resistant Epilepsy
- Interventions
- First Posted Date
- 2021-01-20
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- ES Therapeutics Australia Pty Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT04714996
- Locations
- 🇦🇺
Royal Melbourne Hospital, Parkville, Victoria, Australia
🇦🇺Alfred Health, Melbourne, Victoria, Australia
🇦🇺Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
© Copyright 2025. All Rights Reserved by MedPath